✦ LIBER ✦

Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis

✍ Scribed by Stefan Fruehauf; Julian Topaly; Eike C. Buss; Thomas Fischer; Oliver G. Ottmann; Bertold Emmerich; Martin C. Müller; Peter Schuld; Leopold Balleisen; Rüdiger Hehlmann; Anthony D. Ho; Andreas Hochhaus

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 118 KB
Volume: 109
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22535

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sudden blast crisis in patients with Phi

Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy

✍ Giuliana Alimena; Massimo Breccia; Roberto Latagliata; Ida Carmosino; Eleonora R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

Erythropoietin is effective in improving

Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phase

✍ Jorge Cortes; Susan O'Brien; Alfonso Quintas; Francis Giles; Jianquin Shan; Mary 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND Myelosuppression occurs in up to 50% of patients with chronic myeloid leukemia (CML) who are treated with imatinib and ≥ Grade 3 myelosuppression is reported in approximately 10% of patients. ## METHODS The authors investigated the prognostic significance of anemia occu